Literature DB >> 823847

Phage type of tubercle bacilli isolated from patients with two or more sites of organ involvement.

J H Bates, W W Stead, T A Rado.   

Abstract

To evaluate the possibility of separate pulmonary infections in human beings by different strains of Mycobacterium tuberculosis, a search for multiple phage types within a single host was under-taken. Culture isolates from 2 or more distinct anatomic sites of infection in the same patient were obtained from 87 persons. In 3 subjects, 2 distinct phage types were found. The possible explanations for 2 types in the same patient and the epidemiologic implications are discussed.

Entities:  

Mesh:

Year:  1976        PMID: 823847     DOI: 10.1164/arrd.1976.114.2.353

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  17 in total

1.  Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical Isolates.

Authors:  Chao Zheng; Song Li; Zhongyue Luo; Rui Pi; Honghu Sun; Qingxia He; Ke Tang; Mei Luo; Yuqing Li; David Couvin; Nalin Rastogi; Qun Sun
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

2.  Mixed tuberculosis infections in rural South Vietnam.

Authors:  Mai N T Huyen; Kristin Kremer; Nguyen T N Lan; Frank G J Cobelens; Tran N Buu; Nguyen H Dung; Maxine Caws; Edine W Tiemersma; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

3.  Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow Cytometry-Based Phenotyping and Whole-Genome Sequencing.

Authors:  Max R O'Donnell; Michelle H Larsen; Tyler S Brown; Paras Jain; Vanisha Munsamy; Allison Wolf; Lorenzo Uccellini; Farina Karim; Tulio de Oliveira; Barun Mathema; William R Jacobs; Alexander Pym
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

4.  Bacterial Genotyping of Central Nervous System Tuberculosis in South Africa: Heterogenic Mycobacterium tuberculosis Infection and Predominance of Lineage 4.

Authors:  L M van Leeuwen; P Versteegen; S D Zaharie; S L van Elsland; A Jordaan; E M Streicher; R M Warren; M van der Kuip; A M van Furth
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 5.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

Review 6.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Epidemiology of tuberculosis on Gran Canaria: a 4 year population study using traditional and molecular approaches.

Authors:  M J Pena; J A Caminero; M I Campos-Herrero; J C Rodríguez-Gallego; M I García-Laorden; P Cabrera; M J Torres; B Lafarga; F Rodríguez de Castro; S Samper; F Cañas; D A Enarson; C Martín
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

8.  Molecular characterization of Mycobacterium bovis isolates from Ethiopian cattle.

Authors:  Demelash Biffa; Eystein Skjerve; James Oloya; Asseged Bogale; Fekadu Abebe; Ulf Dahle; Jon Bohlin; Berit Djønne
Journal:  BMC Vet Res       Date:  2010-05-27       Impact factor: 2.741

9.  Multiple Mycobacterium tuberculosis strains in early cultures from patients in a high-incidence community setting.

Authors:  Madalene Richardson; Nora M Carroll; Erica Engelke; Gian D Van Der Spuy; Faeeza Salker; Zahn Munch; Robert P Gie; Robin M Warren; Nulda Beyers; Paul D Van Helden
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Reinfection tuberculosis: two cases in the family of a patient with drug-resistant disease.

Authors:  P Ormerod; C Skinner
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.